Life Sciences Times

Juno Diagnostics Announces Closing of $25 Million Series A Financing Led by Perceptive Xontogeny Venture Fund

Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally Bioavailable Drugs for the Treatment of Dyslipidemia

Tellus Therapeutics Secures Seed Financing to Develop the First Treatment for Newborns with White Matter Brain Injury

Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals

Autobahn Therapeutics Acquires Clinical-Stage FAAH Inhibitor from Astellas

Alvotech Seeks to End AbbVie’s Wrongful Monopoly on Humira and Bring Affordable Arthritis Treatment to U.S.

908 Devices Launches New Aerosol Module for Handheld MX908

IQHQ Demonstrates its Commitment to Sustainable Development with Strategic Hire

ServiceNow Enhances Vaccine Administration Management, Unveils New Product

Amazentis Pioneers First Sports Nutrition Program with Mitopure™